scholarly article | Q13442814 |
P356 | DOI | 10.1196/ANNALS.1433.049 |
P698 | PubMed publication ID | 18448813 |
P50 | author | Veronika Somoza | Q39183625 |
Katarína Sebekova | Q60490959 | ||
P2093 | author name string | Ines Birlouez-Aragon | |
Cornelia Zumpe | |||
Giselle Saavedra | |||
Kristína Klenovicsová | |||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 177-180 | |
P577 | publication date | 2008-04-01 | |
P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
P1476 | title | Plasma concentration and urinary excretion of N epsilon-(carboxymethyl)lysine in breast milk- and formula-fed infants | |
P478 | volume | 1126 |
Q59662238 | Advanced Glycation End Products and Risks for Chronic Diseases: Intervening Through Lifestyle Modification |
Q38647079 | Advanced glycation End-products (AGEs): an emerging concern for processed food industries |
Q34542291 | Advanced glycation end products in infant formulas do not contribute to insulin resistance associated with their consumption |
Q99555773 | Dietary Advanced Glycation Endproducts and the Gastrointestinal Tract |
Q37591929 | Dietary glycotoxins and infant formulas |
Q24632710 | Does accumulation of advanced glycation end products contribute to the aging phenotype? |
Q92146967 | Early and advanced stages of Maillard reaction in infant formulas: Analysis of available lysine and carboxymethyl-lysine |
Q44462072 | Faox enzymes inhibited Maillard reaction development during storage both in protein glucose model system and low lactose UHT milk |
Q37800817 | Glycation products in infant formulas: chemical, analytical and physiological aspects |
Q37800425 | Health effects of dietary Maillard reaction products: the results of ICARE and other studies. |
Q95828462 | Healthy Eating Recommendations: Good for Reducing Dietary Contribution to the Body's Advanced Glycation/Lipoxidation End Products Pool? |
Q39549971 | Heat treatment of Brussels sprouts retains their ability to induce detoxification enzyme expression in vitro and in vivo |
Q61989156 | Impact of free N-carboxymethyllysine, its precursor glyoxal and AGE-modified BSA on serotonin release from human parietal cells in culture |
Q36796216 | Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift |
Q92163626 | Maternal Consumption of a Diet Rich in Maillard Reaction Products Accelerates Neurodevelopment in F1 and Sex-Dependently Affects Behavioral Phenotype in F2 Rat Offspring |
Q34153508 | Maternally transmitted and food-derived glycotoxins: a factor preconditioning the young to diabetes? |
Q38108373 | Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology. |
Q39140530 | N(ε)-Carboxymethyllysine (CML), a Maillard reaction product, stimulates serotonin release and activates the receptor for advanced glycation end products (RAGE) in SH-SY5Y cells |
Q41838059 | N(ϵ) -Carboxymethyllysine Increases the Expression of miR-103/143 and Enhances Lipid Accumulation in 3T3-L1 Cells. |
Q92056715 | Optimization of spray drying parameters and food additives to reduce glycation using response surface methodology in powdered infant formulas |
Q28287402 | Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine |
Q38358965 | Prevention of protein glycation by natural compounds. |
Q45970190 | Reference values of skin autofluorescence as an estimation of tissue accumulation of advanced glycation end products in a general Slovak population. |
Q38104109 | Review of the characteristics of food-derived and endogenous ne-carboxymethyllysine |
Q37635808 | Skin advanced glycation end-products evaluation in infants according to the type of feeding and mother's smoking habits |
Q47886368 | The advanced glycation end product Nϵ -carboxymethyllysine and its precursor glyoxal increase serotonin release from Caco-2 cells |
Search more.